Effectiveness of the Use of Personal Protective Equipment in Addition to Tenofovir/Emtricitabine for the Prevention of the Transmission of SARS-COV-2 to Health Care Personnel. Randomized Clinical Trial

Valderrama et al., NCT04519125, NCT04519125, Apr 2021
Estimated 950 participant miscellaneous prophylaxis RCT with results not reported over 4 years after estimated completion.
Important missing comments or errors? Let us know.
Valderrama et al., 1 Apr 2021, Double Blind Randomized Controlled Trial, placebo-controlled, Colombia, trial NCT04519125 (history). Contact: slvalderrama@husi.org.co, cuervoj@javeriana.edu.co.
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0